Replies to post #16707 on OWC Pharmaceutical Research Corp (OWCP)

[Hercules1]

OWCP:



this development is far bigger than meets the eye.


this delivery technology will also be applicable for a multitude of other medical cannabis based drugs and preparations.


it is too risky to not own this stock. this is why I add each and every single week.

http://www.cnbc.com/2016/10/20/pr-newswire-owc-pharmaceutical-research-corp-completes-development-of-its-medical-cannabis-sublingual-tablet.html


Israel has around 250 pharmacies. medical cannabis revolution is about to be unleashed in that country.


this new development is good for $200 million to $300 million in revenues in time.


goldman sachs just placed an acquisition value of $349 a share for gwph.


now this is not rocket science. where do you think we stand with OWCP.


OWCP could command an acquisition value of $30 right this very second.



this is why this is too bloody risky to not own this stock.



in addition, OWCP can license this technology. in fact look for some licensing agreements to be announced shortly.



you do not want to be without this stock.